Profil
Mary L.
Anderson is Vice President of Business Development for Xoma Ltd., which she joined in February 2008.
She was Executive Director of Global Licensing and Business Development for Oncology at Merck-Serono International SA. Ms. Anderson has 20 years of experience in the pharmaceutical and biotechnology industry.
She was Senior Director of Corporate Development for MorphoSys AG, where she was charged with growing the antibody discovery business.
She also held business development positions at Agensys, Inc. and Bayer AG.
Ms. Anderson worked in Research for Chiron and Gen-Probe.
She received an MBA from St. Mary's College of California and a BS degree in Biochemistry from California Polytechnic State University at San Luis Obispo.
Anciens postes connus de Mary L. Anderson
| Sociétés | Poste | Fin |
|---|---|---|
Merck Serono SA
Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Corporate Officer/Principal | - |
| XOMA ROYALTY CORPORATION | Corporate Officer/Principal | - |
Formation de Mary L. Anderson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
XOMA Royalty Corp.
XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
St. Mary's College of California
St. Mary's College of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Polytechnic State University (San Luis Obispo)
California Polytechnic State University (San Luis Obispo) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Serono SA
Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Health Technology |
















